The company will provide the services for the VA's Million Veteran Program, which is studying the link between genes and disease in US veteran volunteers.
ReviveMed's technology uses artificial intelligence-based analysis of metabolomics data for drug discovery and development.
The companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader.
In PNAS this week: genetic diversity of MERS in African camels, centromere evolution in Cryptococcus, and more.
The companies will offer a system for the identification and quantitation of metabolites in biological samples.
In PLOS this week: metabolite profiles of typhoid fever, shifts in cell-free DNA levels following exercise, and more.
The researchers found multiple enzymes that indicate causes of dysregulated adaptive immunity and tissue damage in fatal Ebola virus disease.
Bioage Labs now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.
Investigators are searching for non-invasive biomarkers of rejection and earlier stage graft injury in children and adults who have received kidney transplants.
ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.
The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.
CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.
In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.